Syschem
52.65
-2.28(-4.15%)
Market Cap₹229.08 Cr
PE Ratio52.82
IndustryHealthcare
Company Performance:
1D-4.15%
1M+4.55%
6M+13.74%
1Y+6.09%
5Y+638.43%
View Company Insightsright
More news about Syschem
04Aug 25
Syschem India Reports 24% Revenue Growth in Q1, Expands Production Capacity
Syschem India Limited reported robust Q1 results with total income reaching ₹126.76 crore, a 24% increase year-over-year. Profit before tax surged by 1124% to ₹1.67 crore. The company achieved an 81% increase in production capacity and is constructing a new WHO-GMP compliant manufacturing unit in Kalka, Haryana. Syschem has expanded its presence across 12 Indian states and several international markets. The board made key appointments to strengthen corporate governance and granted stock options to key employees.
Syschem
52.65
-2.28
(-4.15%)
1 Year Returns:+6.09%
Industry Peers
Sun Pharmaceutical
1,760.70
(-1.23%)
Divis Laboratories
6,600.50
(-0.63%)
Torrent Pharmaceuticals
4,026.40
(-1.61%)
Cipla
1,460.60
(-0.50%)
Dr Reddys Laboratories
1,206.90
(-2.89%)
Lupin
2,190.90
(-1.06%)
Mankind Pharma
2,261.20
(-2.19%)
Zydus Life Science
907.55
(-2.16%)
Aurobindo Pharma
1,206.10
(-2.37%)
Alkem Laboratories
5,793.00
(-0.23%)